Posts

October 10, 2014

+
2:03 PM | Go with the flow: lab-on-a-chip devices
Microfluidic, or lab-on-a-chip, devices have been used by pharma scientists for years but are now threatening to break into mainstream use
+
1:30 PM | Right Turn: Why you should vote for Stem Cell Person of the Year
> We assume there is no real argument to be made here. It’s more than just popularity or who has been in the news most often over the past year. The annual call for nominations and the selection of Stem Cell Person of the Year by readers of Paul Knoepfler’s blog – a.k.a. the stem cell...Read more
+
1:10 PM | Friday SNPpets
Welcome to our Friday feature link collection: SNPpets. During the week we come across a lot of links and reads that we think are interesting, but don’t make it to a blog post. Here they are for your enjoyment… RT @AgroBioDiverse: All 115 plant image analysis software solutions… plant-image-analysis.org RT @thinkgenome: UCSC researchers create Ebola genome […]
+
10:58 AM | Endo to acquire Auxilium for $2.6bn
Puts end to takeover deal for QLT
+
10:43 AM | Amgen leukaemia drug gets FDA priority review
Adds to breakthrough status for blinatumomab
+
10:34 AM | Novartis' secukinumab has 'consistent' activity in psoriasis
Reinforces data that suggests drug is more effective than Amgen’s Enbrel
+
9:51 AM | Attestati di prestazione energetica: nuove regole dal 2 ottobre 2014
Dal 2 ottobre 2014 sono entrate in vigore le nuove norme UNI/TS 11300-1 e 2, per il calcolo del fabbisogno di energia termica dell’edificio per la climatizzazione estiva ed invernale e di energia primaria per la climatizzazione invernale, la produzione…Read more →
+
9:16 AM | Fotovoltaico: importanti guadagni dalle manutenzioni, mercato da 350 milioni di euro
Negli anni scorsi il fotovoltaico si è sviluppato sul nostro territorio con diverse centinaia di migliaia di impianti, tutt’ora in esercizio. Con l’avvento del decreto spalma incentivi il fotovoltaico sembra aver persa appeal e, per tale motivo, le aziende che…Read more →
+
6:01 AM | Ecobonus sui grandi elettrodomestici
BUTALI: “SAREBBE SBAGLIATO INTERROMPERE QUANTO FATTO FINO AD ORA PER SOSTENERE I CONSUMI” Unanime il parere dei Rivenditori Specializzati: l’Ecobonus ha prodotto segnali positivi, seppur lievi, per sostenere le vendite dei grandi elettrodomestici. L’incentivo previsto dalla Legge di Stabilità va mantenuto anche per il 2015.Read more →
+
4:00 AM | No Ice Buckets or Pink Ribbons for Very Rare Genetic Diseases
As enthusiasm for dumping ice on one another fades with autumn and October brings pervasive pink, I wish that attention would turn to families confronting diseases not as well known as ALS and breast cancer. HOW RARE IS RARE? According to the National Organization for Rare Disorders, “rare disease” in the U.S. means affecting fewer than 200,000 people. These conditions number about 6,800, collectively affecting nearly 30 million Americans or 1 in 10 people. Many are single-gene […]

October 09, 2014

+
11:30 PM | NHS England invests £120m to tackle mental health
Standards to put mental illness on equal footing with physical health issues
+
11:30 PM | EMG appoints Merck and Boehringer directors as new officers
David Garmon-Jones is new chair and Zinta Krumins is vice chair
+
11:15 PM | Takeda opens new UK office in High Wycombe
Hopes move to larger premises will help expand business
+
11:15 PM | Tonic names Mary Smiddy as global CEO
And Tamsin Tierney is promoted to managing director for Europe
+
10:46 PM | Radiation from nuclear weapons enables measurement of soil erosion
Research published by Professor Paolo Porto and colleagues supports using radioactive caesium-137 measurements for assessing soil erosion over time.1 * Soil erosion leaves less land available for agriculture, pollutes potable water and clogs rivers with sediment. Climate change could exacerbate these effects, so it is crucial to develop reliable methods for quantifying soil erosion. The […]
+
8:31 PM | Twitterbots for NGS
I've been inspired to create three Twitterbots for NGS papers on @RNA-seq, @ChIP-seq and @Exome-seq by Casey Bergman at the University of Manchester. I'd not come across Caseys twitter account (I don't actually use Twitter that much) or his lab website and blog; but I was directed there by a piece on the Nature website...How to tame the flood of literature.What Casey has done is pretty simple and it is very well explained in his blog post, or by Rob Lanfear who has posted instructions on […]
+
7:29 PM | Jimmy Kimmel gives GMOs the Gluten treatment
Jimmy Kimmel jumped into the discussion of the “Gluten-free” trend, showing that many people who avoided wheat gluten did not understand what it was or why they were avoiding it. Now, Jimmy Kimmel has done the same thing with GMOs. He sent a film crew to a farmer’s market to find out if people avoided GMOs, why, and what “GMO” stood for. This is the hilarious result.
+
5:11 PM | SCID-X1 Gene Therapy, Take 2
Beneath all the bad news about viruses this week lies a good virus: the one that underlies gene therapy for X-linked severe combined immunodeficiency (SCID-X1). Altered viruses are the vehicles that transfer healthy human genes into the cells of people … Continue reading »The post SCID-X1 Gene Therapy, Take 2 appeared first on DNA Science Blog.
+
5:06 PM | Giovane italiano scopre la pulsar più luminosa mai ossservata fino ad’ora
La scoperta, effettuata da un team di astronomi guidato dall’italiano Matteo Bachetti, è stata effettuata con l’ausilio del telescopio spaziale NuSTAR (Nuclear Spectroscopic Telescope Array) della Nasa. Dapprima si pensava che le emissioni luminose fossero riconducibili ala presenza dei buchi…Read more →
+
4:29 PM | Inspiring Stories from the Bench
Tweet This Post
+
4:00 PM | Obesogens: The epigenetic interaction between nature and nurture on risk of obesity
More than 35% of the U.S. population is considered clinically obese (body mass index of > 30), while 68% of the U.S. is considered overweight (body mass index of > 25) 1. Obesity is known to have adverse health effects, impacting the risk and prognosis for a number of diseases, ... The post Obesogens: The epigenetic interaction between nature and nurture on risk of obesity appeared first on EpiBeat.
+
1:41 PM | What’s The Answer? (what do bioinformatics folks use?)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
1:00 PM | Regenerative Medicine Deal Review: September
Welcome to your deal review for the month of September. There was some healthy news flow around cell-based immunotherapy companies this past month, heating up a space that is already ablaze with activity. Undoubtedly the company that took the spotlight was Adaptimmune, which completed a venture capital (VC) round of over $100 million! The money...Read more
+
12:55 PM | FDA IT Upgrades To Improve Medical Device 510(k) And De Novo Processes
The FDA is moving forward with a series of upgrades to its IT infrastructure that will have a direct impact on how medical device companies submit and interact with 510(k) submissions as well as participate in the de novo process. The changes are intended to make communication between the FDA and manufacturers more efficient, as well ... continue reading
+
10:35 AM | Amgen biosimilar matches AbbVie's Humira in psoriasis trial
ABP 501 set to compete with world’s biggest-selling drug
+
10:29 AM | Pfizer reports progress with meningitis vaccine
Race to US market heats up
+
10:16 AM | Germany, UK and Denmark lead mental health integration
But Janssen-backed report says progress is still needed in Europe
+
10:00 AM | In Indonesia sono state ritrovate le pitture rupestri più antiche al mondo
In Indonesia sono state ritrovate le pitture rupestri più antiche al mondo. Nell’isola di sulawesi, all’interno di una grotta, i ricercatori hanno scoperto segni rupestri di circa 40 mila anni fa, come riportato su Nature. Il team di ricercatori è…Read more →
+
9:36 AM | UK biotech leaders partner on science lobbying
The BIA, Bionow, BioPartner and One Nucleus will work together on influencing government policy
+
9:15 AM | Novartis announces departures of three execs
Follows deals to sell divisions to GSK and Lilly
123456789
321 Results